Advanced Vaginal Carcinoma: Clinical Trials

2 trials for Advanced Vaginal Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Recruiting 1

Follow Advanced Vaginal Carcinoma: new trials by email Literature Review of Advanced Vaginal Carcinoma trials Research Report on Advanced Vaginal Carcinoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
Clinical Encounter, Home Health Encounter, Quality-of-Life Assessment - Advanced Anal Carcinoma, Advanced Biliary Tract Carcinoma
Phase 2RecruitingMayo Clinic2202023-08-232026-04-20
Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Metastatic Cervical, Vaginal, or Vulvar Cancers
Durvalumab, Laboratory Biomarker Analysis, Stereotactic Radiosurgery - Advanced Cervical Adenocarcinoma, Advanced Vaginal Carcinoma
Phase 1CompletedM.D. Anderson Cancer Center202018-07-182023-09-13

Narrower conditions

Multiple Myeloma (1)  ·  Myelodysplastic Syndromes (1)  ·  Uterine Cervical Neoplasms (1)  ·  Vaginal Neoplasms (1)  ·  Vulvar Neoplasms (1)

Broader conditions

Neoplasms (2)  ·  Blood Protein Disorders (1)  ·  Bone Marrow Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Female (1)  ·  Genital Neoplasms, Female (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Hemorrhagic Disorders (1)  ·  Hemostatic Disorders (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)

Interventions

Disulfides (1)  ·  Home Care Services (1)  ·  House Calls (1)  ·  Immunoglobulin G (1)  ·  Radiosurgery (1)  ·  durvalumab (1)  ·  tremelimumab (1)

Sponsors

M.D. Anderson Cancer Center (1)  ·  Mayo Clinic (1)

Countries

United States (2)

Top investigators

Lilie L Lin (1)  ·  Roxana S. Dronca, MD (1)